Evidence mapPaperPMID 36222818Full record

ArticleJMIR mental health2022

A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: Single-Arm Longitudinal Pilot Study.

Daniel Guinart, Michael Sobolev, Bhagyashree Patil, Megan Walsh, John M Kane

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR mental health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04191876 (Financial Incentives to Improve Medication Adherence), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04191876 nacompletednot on this map

Financial Incentives to Improve Medication Adherence: a Pilot Study

TypeinterventionalSponsorNorthwell HealthRan2019 to 2022Enrolled25ConditionsSchizophrenia, Schizo Affective Disorder, Bipolar Disorder, DepressionArmsWellth - Financial Incentives
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Daniel GuinartDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United States.ORCID https://orcid.org/0000-0001-5078-6716
Michael SobolevDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United States.ORCID https://orcid.org/0000-0002-8931-7682
Bhagyashree PatilDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United States.ORCID https://orcid.org/0000-0003-1031-5869
Megan WalshDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United States.ORCID https://orcid.org/0000-0002-3091-2145
John M KaneDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United States.ORCID https://orcid.org/0000-0002-2628-9442
Feinstein Institute for Medical Research · USZucker Hillside Hospital · USCornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication nonadherence is prevalent in severe mental illness and is associated with multiple negative outcomes. Mobile technology and financial incentives show promise to improve medication adherence; however, studies in mental health, especially with oral medications, are lacking.

objectiveThe aim of this paper is to assess the feasibility and effectiveness of offering financial incentives through a mobile app based on behavioral economics principles to improve medication adherence in severe mental illness.

methodsA 10-week, single-arm longitudinal pilot study was conducted. Patients earned rewards in the context of app-based adherence incentives. The reward was split into biweekly payments made in increments of US $15, minus any US $2 per day penalties for missed check-ins. Time-varying effect modeling was used to summarize the patients' response during the study.

resultsA total of 25 patients were enrolled in this pilot study, of which 72% (n=18) were female, and 48% (n=12) were of a White racial background. Median age was 24 (Q1-Q3: 20.5-30) years. Participants were more frequently diagnosed with schizophrenia and related disorders (n=9, 36%), followed by major depressive disorder (n=8, 32%). App engagement and medication adherence in the first 2 weeks were higher than in the last 8 weeks of the study. At study endpoint, app engagement remained high (n=24, Z=-3.17; P<.001), but medication adherence was not different from baseline (n=24, Z=-0.59; P=.28).

conclusionsFinancial incentives were effectively delivered using an app and led to high engagement throughout the study and a significantly increased medication adherence for 2 weeks. Leveraging behavioral economics and mobile health technology can increase medication adherence in the short term.

trial registrationClinicalTrials.gov NCT04191876; https://clinicaltrials.gov/ct2/show/NCT04191876.

Indexed as

adherenceantipsychoticdigitalfinancial incentivesmHealthmobile health

Identifiers

PMID36222818
PMCPMC9607890
OpenAlexW4289600569

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.